BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16812)

  • 1. Ditazole and platelets. I. Effect of ditazole on human platelet function in vitro.
    De Gaetano G; Tonolli MC; Bertoni MP; Roncaglioni MC
    Haemostasis; 1977; 6(2):127-36. PubMed ID: 16812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ditazole and platelets. II. Effect of ditazole on in vivo platelet aggregation and bleeding time in rats.
    De Gaetano G; Cavenaghi AE; Stella L
    Haemostasis; 1977; 6(3):190-6. PubMed ID: 18382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro investigation on the antiaggregating activity of ditazole.
    Prisco D; Favilla S; Fortini A; Gensini GF
    Int J Clin Pharmacol Res; 1984; 4(5):341-7. PubMed ID: 6151552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of clot retraction from platelet granule fusion and degranulation: an ultrastructural study of Reptilase-human platelet-rich plasma clots.
    De Clerck F; Borgers M; de Gaetano G; Vermylen J
    Br J Haematol; 1975 Feb; 29(2):341-8. PubMed ID: 1191554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity ratio between antiprostacyclin and antiaggregating effects of acetylsalicylic acid, indometacin and ditazole.
    Caprino L; Togna G; Antonetti F; Borrelli F
    Arzneimittelforschung; 1980; 30(3):406-9. PubMed ID: 6104493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a single Ditazole dose on platelet aggregation and prostaglandin formation.
    Prisco D; Bartoletti A; Lombardi A
    Int J Clin Pharmacol Res; 1984; 4(2):129-36. PubMed ID: 6147319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated reptilase clot retraction of dog platelet-rich plasma: differences with human platelet-rich plasma.
    De Clerck F; Verheyen A; Vermylen J; Reneman R
    Scand J Haematol; 1975 Dec; 15(5):347-58. PubMed ID: 1202624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat.
    Clowes AW; Karnovsky MJ
    Lab Invest; 1977 Apr; 36(4):452-64. PubMed ID: 846193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ditazole and platelets III. Effect of ditazole on tumor-cell induced thrombocytopenia and on bleeding time in mice.
    Mussoni L; Poggi A; Donati MB; de Gaetano G
    Haemostasis; 1977; 6(4):260-5. PubMed ID: 21124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interactions between ditazole and anticoagulant drugs.
    Caprino L; Falchetti R; Borrelli F
    Arzneimittelforschung; 1975; 25(12):1920-3. PubMed ID: 56180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of mithramycin on some platelet functions in vitro.
    Kubisz P; Klener P; Cronberg S
    Acta Haematol; 1980; 63(2):101-6. PubMed ID: 6445152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents.
    Kirkpatrick JP; McIntire LV; Moake JL; Cimo PL
    Thromb Haemost; 1980 Feb; 42(5):1483-9. PubMed ID: 6892735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of teniposide on platelet functions in vitro.
    Kubisz P; Seghier F; DobrotorĂ¡ M; Stasko J; Cronberg S
    Thromb Res; 1995 Jan; 77(2):145-8. PubMed ID: 7740506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood levels of ditazole and inhibition of platelet aggregation in man.
    de Gaetano G; Dal Bo L; Villa S; Mussini E; Marcucci F
    Arzneimittelforschung; 1980; 30(3):496-7. PubMed ID: 6104495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors responsible for ADP-induced release reaction of human platelets.
    Mustard JF; Perry DW; Kinlough-Rathbone RL; Packham MA
    Am J Physiol; 1975 Jun; 228(6):1757-65. PubMed ID: 50744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of aspirin and indomethacin on the platelet contractile wave.
    Gerrard JM; White JG
    Am J Pathol; 1976 Mar; 82(3):513-26. PubMed ID: 1258974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
    Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
    Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease and cyclooxygenase inhibitors synergistically prevent activation of human platelets.
    Ruggiero M; Lapetina EG
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3456-9. PubMed ID: 3458190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.